INVESTIGATION OF THE STABILITY OF DOXORUBICIN HYDROCHLORIDE USING FACTORIAL DESIGN

被引:16
作者
GUPTA, PK
LAM, FC
HUNG, CT
机构
[1] UNIV OTAGO,DEPT PHARM,DUNEDIN,NEW ZEALAND
[2] UNIV OTAGO,DEPT MATH & STAT,DUNEDIN,NEW ZEALAND
关键词
D O I
10.3109/03639048809151980
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:1657 / 1671
页数:15
相关论文
共 28 条
[1]  
[Anonymous], 1976, MERCK INDEX, V9th
[2]   ADRIAMYCIN - NEW ANTICANCER DRUG WITH SIGNIFICANT CLINICAL ACTIVITY [J].
BLUM, RH ;
CARTER, SK .
ANNALS OF INTERNAL MEDICINE, 1974, 80 (02) :249-259
[3]   FACTORIAL-DESIGNS IN PHARMACEUTICAL STABILITY STUDIES [J].
BOLTON, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (04) :362-366
[4]  
BOWEN J, 1981, P AM ASSOC CANC RES, V22, P354
[5]  
BOX GEP, 1978, STATISTICS EXPT
[6]   ADRIAMYCIN - REVIEW [J].
CARTER, SK .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1975, 55 (06) :1265-1274
[7]  
Davies L., 1993, DESIGN ANAL IND EXPT
[8]  
DIMARCO A, 1969, CANCER CHEMOTH REP 1, V53, P33
[9]   REVERSED-PHASE ION-PAIR HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF ADRIAMYCIN AND ADRIAMYCINOL IN RAT SERUM AND TISSUES [J].
GALLO, JM ;
HUNG, CT ;
PERRIER, DG .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1986, 4 (04) :483-490
[10]  
GUPTA P, UNPUB